Home/Filings/4/0001209191-20-023715
4//SEC Filing

Gibbs Craig S 4

Accession 0001209191-20-023715

CIK 0001667633other

Filed

Apr 6, 8:00 PM ET

Accepted

Apr 7, 12:17 PM ET

Size

24.3 KB

Accession

0001209191-20-023715

Insider Transaction Report

Form 4
Period: 2020-04-07
Gibbs Craig S
Chief Business Officer
Transactions
  • Gift

    Common Stock

    2020-04-019,1249,124 total(indirect: By Trust)
  • Disposition to Issuer

    Common Stock

    2020-04-079,1240 total(indirect: By Trust)
  • Disposition to Issuer

    Common Stock

    2020-04-0747,3270 total(indirect: By Trust)
  • Disposition to Issuer

    Stock Option (right to buy)

    2020-04-0764,5150 total
    Exercise: $5.27Exp: 2027-11-27Common Stock (64,515 underlying)
  • Disposition to Issuer

    Common Stock

    2020-04-0747,3270 total(indirect: By Trust)
  • Disposition to Issuer

    Stock Option (right to buy)

    2020-04-07112,9030 total
    Exercise: $2.02Exp: 2026-01-21Common Stock (112,903 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2020-04-0760,2350 total
    Exercise: $35.75Exp: 2029-12-12Common Stock (60,235 underlying)
  • Disposition to Issuer

    Common Stock

    2020-04-075,9240 total
  • Disposition to Issuer

    Stock Option (right to buy)

    2020-04-0772,9020 total
    Exercise: $8.76Exp: 2028-04-26Common Stock (72,902 underlying)
Footnotes (9)
  • [F1]Shares held by Craig Stafford Gibbs & Kit Gibbs, Trustees of the Craig S. & Kit Gibbs Living Family Trust dated December 19, 2001.
  • [F2]Disposed of pursuant to an agreement and plan of merger by and between the Issuer, Gilead Sciences, Inc. ("Gilead") and Toro Merger Sub, Inc. ("Purchaser") (the "Merger") in exchange for $95.50 per share, net to the holder in cash, without interest and subject to any withholding of taxes, upon the terms and subject to the conditions described in the Offer to Purchase dated March 10, 2020 (together with any amendments or supplements thereto, the "Offer to Purchase") and in the accompanying Letter of Transmittal (together with any amendments or supplements thereto), which are annexed to and filed with the Schedule TO as Exhibits (a)(1)(A) and (a)(1)(B), respectively.
  • [F3]Shares held by Craig Stafford Gibbs, Trustee of the Craig Stafford Gibbs 2018 Annuity Trust dated June 7, 2018.
  • [F4]Shares held by Craig Stafford Gibbs, Trustee of the Kit Gibbs 2018 Annuity Trust dated June 7, 2018.
  • [F5]Represents shares acquired under the Forty Seven, Inc. 2018 Employee Stock Purchase Plan.
  • [F6]This option was canceled in the Merger in exchange for a cash payment of $10,554,736.96, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option.
  • [F7]This option, which provided for vesting over a four-year period as follows: 1/48th of the shares subject to the option vest in a series of 48 successive equal monthly installments beginning November 8, 2017, subject to Reporting Person's continuous service as of each such date, was accelerated and canceled in the Merger in exchange for a cash payment of $5,821,188.45, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option.
  • [F8]This option, which provided for vesting over a four-year period as follows: 1/48th of the shares subject to the option vest in a series of 48 successive equal monthly installments beginning March 1, 2019, subject to Reporting Person's continuous service as of each such date, was accelerated and canceled in the Merger in exchange for a cash payment of $6,323,701.74, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option.
  • [F9]This option, which provided for vesting over a four-year period as follows: 1/48th of the shares subject to the option vest in a series of 48 successive equal monthly installments beginning December 13, 2019, subject to Reporting Person's continuous service as of each such date, was accelerated and canceled in the Merger in exchange for a cash payment of $3,599,041.25, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option.

Issuer

Forty Seven, Inc.

CIK 0001667633

Entity typeother

Related Parties

1
  • filerCIK 0001614856

Filing Metadata

Form type
4
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 12:17 PM ET
Size
24.3 KB